Name | 8-Bromo-cAMP, sodium salt,8-Bromoadenosine-3',5'-cyclicmonophosphatesodiumsalt |
---|---|
Synonyms |
4H-Furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-8-bromo-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, sodium salt, (4aR,6R,7R,7aS)- (1:1)
8-BROMOADENOSINE 3':5'-CYCLICMONOPHOSPHA TE SODIUM CAMP,8-BR,NA 8-BROMOADENOSINE-3',5'-CYCLOPHOSPHATE SODIUM SALT 8-BR-CAMP NA Sodium (4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide 8-BROMO-CAMP,NA 8-bromoadenosine 3:5-cyclic*monophosphate sodiu 8-BROMO-CAMP,SODIUM SALT 8-BR-CAMP SODIUM SALT 8-Bromoadenosine 3',5'-phosphoric acid sodium salt MFCD00005844 8-BROM-ADENOSIN-3',5'-CYCLOPHOSPHAT |
Description | 8-Bromo-cAMP sodium salt (8-Br-Camp sodium salt), a cyclic AMP analog, is an activator of cyclic AMP-dependent protein kinase (PKA)[1]. |
---|---|
Related Catalog | |
Target |
PKA[1] |
In Vitro | 8-Bromo-cAMP sodium salt is a brominated derivative of cyclic AMP. 8-Bromo-cAMP sodium salt enhances the efficiency of cellular reprogramming. 8-Bromo-cAMP sodium salt improves the reprogramming efficiency of human neonatal foreskin fibroblast (HFF1) cells. 8-Bromo-cAMP sodium salt inhibits proliferation, induce differentiation and apoptosis in a malignant glioma cell line (A-172) and an esophageal cancer cell line (Eca-109)[1]. |
References |
Molecular Formula | C10H10BrN5NaO6P |
---|---|
Molecular Weight | 430.08 |
Exact Mass | 428.944977 |
PSA | 167.48000 |
LogP | 0.96450 |
Storage condition | −20°C |
Water Solubility | H2O: 100 mg/mL |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | 22-24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |